TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
PHASE1
This is a Phase I, open-label, 3-period crossover trial to investigate the ...
Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)
N/A
Efficacy of etravirin + raltegravir dual therapy was showed in the ANRS 153...
Status
Completed
Location
Yasmine Dudoit
Start Date
2018-01-02
Trial ID
NCT03369743
TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.
PHASE1
The purpose of the study is to determine the effect of steady-state concent...
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
PHASE2
This is a study to assess long-term safety and efficacy of lersivirine in p...
A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study
PHASE2
The purpose of this study is to evaluate the long-term safety and tolerabil...